Smeijsters, E.H.; van der Elst, K.C.M.; Visch, A.; Göbel, C.; Loeff, F.C.; Rispens, T.; Huitema, A.D.R.; van Luin, M.; El Amrani, M.
Optimization of a Quantitative Anti-Drug Antibodies against Infliximab Assay with the Liquid Chromatography-Tandem Mass Spectrometry: A Method Validation Study and Future Perspectives. Pharmaceutics 2023, 15, 1477.
https://doi.org/10.3390/pharmaceutics15051477
AMA Style
Smeijsters EH, van der Elst KCM, Visch A, Göbel C, Loeff FC, Rispens T, Huitema ADR, van Luin M, El Amrani M.
Optimization of a Quantitative Anti-Drug Antibodies against Infliximab Assay with the Liquid Chromatography-Tandem Mass Spectrometry: A Method Validation Study and Future Perspectives. Pharmaceutics. 2023; 15(5):1477.
https://doi.org/10.3390/pharmaceutics15051477
Chicago/Turabian Style
Smeijsters, Erin H., Kim C. M. van der Elst, Amy Visch, Camiel Göbel, Floris C. Loeff, Theo Rispens, Alwin D. R. Huitema, Matthijs van Luin, and Mohsin El Amrani.
2023. "Optimization of a Quantitative Anti-Drug Antibodies against Infliximab Assay with the Liquid Chromatography-Tandem Mass Spectrometry: A Method Validation Study and Future Perspectives" Pharmaceutics 15, no. 5: 1477.
https://doi.org/10.3390/pharmaceutics15051477
APA Style
Smeijsters, E. H., van der Elst, K. C. M., Visch, A., Göbel, C., Loeff, F. C., Rispens, T., Huitema, A. D. R., van Luin, M., & El Amrani, M.
(2023). Optimization of a Quantitative Anti-Drug Antibodies against Infliximab Assay with the Liquid Chromatography-Tandem Mass Spectrometry: A Method Validation Study and Future Perspectives. Pharmaceutics, 15(5), 1477.
https://doi.org/10.3390/pharmaceutics15051477
